George Laszlo just posted about Microsoft’s recent announcement of the BioIT Alliance. His post includes the sort of positioning that makes no sense to me. At one level, Mr. Laszlo presents some quotes from the press release, and some reasonable commentary thereon. It could well be that Microsoft is “…simply playing catch-up here with IBM,” as Mr. Laszlo’s analysis says.
But Mr. Laszlo appears to have made little effort to understand what Microsoft is doing, and he throws innuendo around without citing any first-hand sources. “Hopefully they are serious about this and will not disappoint the alliance members. We shall see.” Has he talked to disappointed alliance members? He doen’t say. “…exactly what chance will other software or service providers have to break into this club?” Has he asked to join and been turned away? He doesn’t say.
So — firsthand, Mr. Laszlo — let me answer your questions. I am the CEO of a founding member of the BioIT Alliance, not in any way affiliated with Microsoft. I have worked directly with Don Rule, who has been leading the charge at Microsoft on this, and he has in no way “disappointed” this partner. He’s energetic and determined, and has been a pleasure to work with. For that matter, Bill Gates’ own views and commitment in this area date from long before this announcement — as anyone “following the discovery space for the past 5 years” should know.
Oh - and I “broke into this club” by asking to be invited. I articulated a vision of how our products and services can advance the (extremely worthy) goals of the organziation, including those articulated by Mr. Gates in the original BioIT Alliance announcement. Before breaking in, try the front door.
Mr. Laszlo also states that his “…personal concern is that the alliance will be swayed to use Microsoft products and thus become ‘closed minded’ when it comes to finding the best solution to a given problem.” Is it so shocking that Microsoft would put its money, reputation, and partners on the line to demonstrate that its product groups and partner ecosystem might actually be able to contribute more to this field? Is it so concerning that Microsoft and its partners would put forward an initiative to serve an important and growing market with products that can be adapted for that market? And if those products are indeed, as Mr. Laszlo suggests, not currently “…the best, most elegant or cost effective” way to meet the needs of that market, is it so surprising that Microsoft and its partners would choose to improve those products through direct engagement in the market?
I find Microsoft’s growing commitment to serving this market most encouraging. Mr. Laszlo is right in implying that BioIT Alliance members will only succeed in this initiative if we bring forward solutions that are ”…the best, most elegant, and cost effective.” Will we succeed? “We shall see.”
Tags: Bio-IT-World, BioIT-Alliance, Microsoft
